Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) saw unusually large options trading on Thursday. Investors bought 33,742 call options on the stock. This represents an increase of approximately 66% compared to the average volume of 20,354 call options.
Teladoc Health Trading Down 2.5 %
NYSE TDOC opened at $9.16 on Friday. The firm has a market cap of $1.59 billion, a P/E ratio of -1.59 and a beta of 1.27. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The stock’s 50-day moving average is $10.62 and its 200-day moving average is $9.61. Teladoc Health has a one year low of $6.76 and a one year high of $15.95.
Teladoc Health (NYSE:TDOC – Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). The business had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Sell-side analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Teladoc Health
Analyst Upgrades and Downgrades
TDOC has been the topic of several research reports. Oppenheimer cut their price target on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday, January 24th. Royal Bank of Canada upped their price target on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Piper Sandler cut their price target on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday, February 27th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. Finally, The Goldman Sachs Group cut their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research note on Monday, March 3rd. Eleven research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, Teladoc Health presently has an average rating of “Hold” and a consensus price target of $11.26.
View Our Latest Stock Analysis on TDOC
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
- Five stocks we like better than Teladoc Health
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Is Myers Industries Poised for a Breakout?
- What Makes a Stock a Good Dividend Stock?
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.